1. Home
  2. EXAS vs NWS Comparison

EXAS vs NWS Comparison

Compare EXAS & NWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.91

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Logo News Corporation Class B

NWS

News Corporation Class B

HOLD

Current Price

$30.07

Market Cap

16.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXAS
NWS
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.3B
16.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EXAS
NWS
Price
$101.91
$30.07
Analyst Decision
Buy
Strong Buy
Analyst Count
20
6
Target Price
$77.94
$37.34
AVG Volume (30 Days)
4.9M
982.0K
Earning Date
02-18-2026
02-04-2026
Dividend Yield
N/A
0.67%
EPS Growth
N/A
230.83
EPS
N/A
2.06
Revenue
$3,082,033,000.00
$8,500,000,000.00
Revenue This Year
$19.40
$5.13
Revenue Next Year
$13.51
$3.30
P/E Ratio
N/A
$13.04
Revenue Growth
14.47
2.20
52 Week Low
$38.81
$26.25
52 Week High
$102.66
$35.58

Technical Indicators

Market Signals
Indicator
EXAS
NWS
Relative Strength Index (RSI) 85.29 56.79
Support Level $101.45 $29.81
Resistance Level $102.00 $30.24
Average True Range (ATR) 0.39 0.46
MACD -1.26 0.07
Stochastic Oscillator 88.69 77.88

Price Performance

Historical Comparison
EXAS
NWS

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About NWS News Corporation Class B

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: